SXTC

China SXT Pharmaceuticals, Inc. [SXTC] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

SXTC Stock Summary

Top 10 Correlated Stocks

SXTC

In the News

SXTC Financial details

Company Rating
-
Market Cap
14.62M
Income
-8.15M
Revenue
2.35M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
88
Optionable
No
Shortable
Yes
Earnings
17 Jul 2023
P/E
-0.45
Forward P/E
-
PEG
-0.42
P/S
9.92
P/B
0.16
P/C
-
P/FCF
125.37
Quick Ratio
1.23
Current Ratio
1.31
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-6.11
EPS next Y
-
EPS next Q
-
EPS this Y
3.44%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
-22.41%
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-25%
SMA50
-
SMA100
-25%
Inst Own
-
Inst Trans
-
ROA
-17%
ROE
-35%
ROC
-0.32%
Gross Margin
48%
Oper. Margin
-199%
Profit Margin
-220%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
1.39-9.375
52W High
-70.56%
52W Low
+164.99%
RSI
44
Rel Volume
0.09
Avg Volume
626.74K
Volume
54.73K
Perf Week
-4.34%
Perf Month
-3.29%
Perf Quarter
-41.76%
Perf Half Y
-54.63%
-
-
-
-
Beta
0.726112
-
-
Volatility
0.09%, 1.11%
Prev Close
3.11%
Price
2.6499
Change
8.15%

Something similar

Top by Market Cap
AMZN
GOOG
FXAIX
FB2A.DE
DHR-PB
Same Sector
BVX.L
0OR2.L
CUE
MODV
AXNX
Top Correlated Stocks
0002.HK
FGFH
SACI.PA
002321.SZ
SCZC
Similar Market Cap
HSTI
PLAT
SNTW
3BP.L
FLXG.L

Company Profile

Healthcare Drug Manufacturers - Specialty & Generic
  • Volume Average 626.74K
  • Market Capitalization 14.62M
  • Employee 88
  • CEO Mr. Feng Zhou
  • Headquarters Taizhou,CN
  • IPO Date 2019-01-04
  • Website https://www.sxtchina.com

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine piece tablets (TCMP) in China. The company offers advanced, fine, and regular TCMP products, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. As of March 31, 2022, it had an end-customer base of 68 pharmaceutical companies, 14 chain pharmacies, and 20 hospitals in 10 provinces and municipalities in China. The company was founded in 2005 and is headquartered in Taizhou, China.